'It is not just the US and European opportunity, but it is a huge global opportunity.'
Department of Pharmaceuticals asks NPPA to review Eli Lilly product prices.
However, Cipla was very clear it does not want to get into vaccine manufacturing.
The drug regulator recently asked some domestic companies to cut prices of insulin while MNCs, which are major players, are allowed to set their own price for the drug.
'However, we have seen weakness in our active pharmaceutical ingredients business.'
Another cap for imported insulin; domestic manufacturers cry foul.
The ministry has asked 44 pharmaceutical companies, including global drug majors such as Eli Lilly, Novartis, Pfizer, Bayer, Merck, Johnson & Johnson and Sanofi Aventis, to explain why they have not given the compensation, which is mandatory under the current drug laws.
Major drug discovery outsourcing deals have almost dried up in the past 18 months for almost all prominent players in the area
The medicines whose prices have been reduced belong to therapeutic categories, like dexametozone, betamethazone, ampicillin and ranitidine. The prices of some multi-vitamins and antibiotics would rise a bit.
US-based Eli Lilly has planned to continue its focus on innovation-driven products, instead of opening up to opportunities in off-patent generic drugs, being tapped by its larger competitors like GSK and Pfizer.
A sampling of ideas from the next generation of consumers -- and entrepreneurs.
Eli Lily, Sanofi Aventis, Bristol Myers approach chemicals ministry.
United States' Food and Drug Administration has granted approval to Ranbaxy Laboratories Ltd to manufacture and market 40 mg capsules of Fluoxetine, a drug used in treatment of obsessive-compulsive disorders.\n\n
If you get stuck with business-as-usual, you get left behind.
The Supreme Court will decide whether domestic companies must deduct tax at source on salaries paid to their expatriate staff and if tax can be levied on these employees on wages given abroad by foreign joint venture partners of the Indian firms.
Leading insulin makers on Friday slashed the rates of human insulin by about 40 per cent, a move which will provide a big relief to diabetic patients.
Drugmaker Dr Reddy's Laboratories has filed an application with the US Food and Drug Administration to market a generic form of Eli Lilly's schizophrenia drug Olanzapine in the US
'I want everybody to be given the same treatment as your president because I feel great. I feel like perfect'
Experts say despite it being a global deal, the transaction will have to undergo CCI scrutiny because of the scale of operations.
Apart from Wockhardt, only Biocon manufactures insulin analog indigenously.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances